Ticker brief

MRVI

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
21
authors 14d
13
crowd 14d
+0.9σ

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-28 · now +0.30 (−1 bearish … +1 bullish)
Who spoke13
authorgradetrader scoresignalsmean sent
@Brad_E_SchulzC·4+0.60
@SittingBear0921C+0.223+0.47
@fundmyfundB-1.582+0.60
@OptionsFlowBossC·2+0.38
@spluscollectiveC+0.462+0.42
@TrendSpiderC-1.011+0.30
@KakashiCapital_B-0.151+0.45
@SandmanMarketsC-2.911+0.50
@HedgeFundTipsB+0.491+0.20
@AlertsAndNewsC-1.901+0.20
@equityddC-2.031+0.30
@AmeetRaiC-1.081+0.65
@MWM76C-1.001+0.45
Recent signals21of 21 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-08-28@SittingBear0921+0.30Claims victory when comparing a basket of named stocks, though supporting context is absent.·
2026-08-26@MWM76+0.45Says the sector is re-rating, with TEM as its leader.·
2026-08-26@fundmyfund+0.65Calls MRVI very strong relative to the choppier TEM·
2026-08-25@AmeetRai+0.65Author identifies MRVI as a cycle performance booster and cites volume, entry level and sector rotation.·
2026-08-23@spluscollective+0.50Maps a personalized-cancer-vaccine supply chain and gives MRNA a conditional 300-plus objective after Phase 3.·
2026-08-23@spluscollective+0.35Reports positive Phase 3 melanoma results and the resulting $92B revaluation across the mRNA complex.·
2026-08-23@SittingBear0921+0.40Claims past successful calls across a broad list of stocks and ETFs.·
2026-08-21@equitydd+0.30Lists leading stocks with the strongest weekly momentum; output is capped at six tickers.·
2026-08-21@AlertsAndNews+0.20Day recap lists completed entries, targets, stops and swing outcomes across multiple tickers.·
2026-08-21@OptionsFlowBoss+0.20Lists unusually high bullish options-volume multiples; later bearish remark is not assigned to named stocks.·
2026-08-21@Brad_E_Schulz+0.40Reports intraday sector performance and names healthcare stocks gaining at least 4%.·
2026-08-21@SittingBear0921+0.70Celebrates a completed winning MRVI idea; other cashtags are incidental criticism.·
2026-08-20@Brad_E_Schulz+0.60Lists stocks up at least 4% on at least 1.5 times average volume; capped at six.·
2026-08-20@OptionsFlowBoss+0.55Lists unusual bullish options-volume multiples for six names.·
2026-08-20@fundmyfund+0.55Names MRVI and TEM among today's winning biotech-AI names.·
2026-08-20@HedgeFundTips+0.20Post presents a list of names receiving money flows today.·
2026-08-19@Brad_E_Schulz+0.70Screens high-volume stocks up at least 5% and reports exact relative-volume and return data; tickers capped at six.·
2026-08-19@SandmanMarkets+0.50Celebrates MRVI crossing a 100% gain threshold after prior analysis.·
2026-08-19@KakashiCapital_+0.45Lists under-discussed stocks of interest in the mRNA and cancer-vaccine theme.·
2026-08-19@TrendSpider+0.30AI scan identifies public companies advancing mRNA technology after a cancer-vaccine breakthrough.·
2026-08-19@Brad_E_Schulz+0.70Screens stocks up at least 8% on elevated volume with exact return and relative-volume data; tickers capped at six.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.